Innate Pharma (IPHA) Operating Margin (2021 - 2024)
Innate Pharma (IPHA) reported Operating Margin of 317.29% for Q2 2024, down 31617.0% on a YoY basis from N/an in Q3 2023, and down 28076.78% quarter-over-quarter from 1.13% in Q2 2023.
Innate Pharma (IPHA) Operating Margin (2021 - 2024) Analysis & Trends
Innate Pharma has reported Operating Margin for 3 years, with the latest figure at 317.29% in Q2 2024.
- For the quarter ending Q2 2024, Operating Margin fell 31617.0% year-over-year to 317.29%; the trailing twelve-month figure through Jun 2024 stood at 46.86% (down 1735.0% YoY), and the FY2025 full-year result was 1937.85%, down 168153.0% from the prior year.
- Operating Margin for Q2 2024 stood at 317.29%, down from 1.13% in the prior quarter.
- The five-year high for Operating Margin was 1.13% in Q2 2023, with the low at 317.29% in Q2 2024.
- Historically, Operating Margin has averaged 170.67% across 3 years, with a median of 193.6% in 2021.
- The largest YoY upside for Operating Margin was 31617 bps in 2024 against a maximum downside of 31617 bps in 2024.
- Innate Pharma's Operating Margin stood at 193.6% in 2021, then soared by 99 bps to 1.13% in 2023, then sank by 28077 bps to 317.29% in 2024.
- The last three Operating Margin figures came in at 317.29% (Q2 2024), 1.13% (Q2 2023), and 193.6% (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Innate Pharma | 194.19 Mn | 194.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -317.29% |
| Jun 30, 2023 | -1.13% |
| Dec 31, 2021 | -193.60% |